Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE).
HR 869/S. 289 RISE Act of 2021
S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research.
Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill.
HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021
Cures 2.0 RFI - DeGette, Upton
ARPA-H Principles

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), White House Office, Centers For Disease Control & Prevention (CDC), State - Dept of (DOS), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Veterans Affairs - Dept of (VA), Energy - Dept of, Transportation - Dept of (DOT)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including:
HR 1946, Multi Cancer Early Detection Screening Coverage Act
HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program.
S. 245, SAME Act of 2021
HR 340, the Incentivizing Medicaid Expansion Act
HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act
HR 1791, the Childrens Health Insurance Permanency Act
Issues related to governance of state Medicaid programs, including work requirements and block grant proposals.
Issues related to the waiting period for SSDI and Medicare.
Home and Community Based Services Access Act
Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap)
Cancer Care Planning and Communications Act, HR 4414
CONNECT Act (telehealth), S. 1512
Lymphedema Treatment Act, HR 3630, S. 1315
Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez
Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TOB

16. Specific lobbying issues

Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including:
Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation;
Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars;
HR 2125, The Quit Because of COVID Act
HR 2786/S 1314 - Tobacco Tax Equity Act of 2021
The Protect Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), White House Office, Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations.
Issues related to stimulus for nonprofit organizations and increasing charitable giving.
WORK NOW Act, HR 1987, S 740
Legacy IRA Act, HR 3832, S. 243

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Federal Reserve System, Small Business Administration (SBA), Treasury - Dept of

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including:
HR 1550, The Prevent HPV Cancers Act
S 464/HR 2163 Safe Step Act
S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021
HR 623, Gabriella Miller Kids First Research Act 2.0
The Palliative Care and Hospice Education and Training Act (soon to be introduced)
Issues related to the proposed HELP workforce proposal.
Issues related to the possible introduction of the 21st Century Cures Act version 2.0
Regulations implementing the No Suprises Act
OMB RFI on health equity - comments
ACA subsidies expansion permanency - next legislative package
Advocacy around subpar health plans - next legislative package
DICT RFI - Eshoo
DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz
House/Senate Appropriations Committee FDA DICT report language
Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis
Personal Care Products Safety Act - Feinstein, Collins
H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021
The VALID Act - DeGette, Bennet, Burr, Buschon

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Food & Drug Administration (FDA), White House Office, State - Dept of (DOS), Natl Institutes of Health (NIH), U.S. Agency for International Development (USAID), Environmental Protection Agency (EPA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes